The company also announced it has initiated AGLOW, a Phase 2 proof-of-concept study of VX-407 for the treatment of ADPKD. VX-407 is an investigational small molecule corrector that is designed to ...

Vertex Pharma has made its name with treatment for cystic fibrosis, but has big plans in cell and genetic therapies – and has just chalked up fast-track status from the FDA for a cell-based therapy ...

Niron Magnetics today announced a donation to the Sartell Police Reserve Program, a key element of the company’s continuous commitment to supporting the local community as it establishes its new ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.